SAM
RCKT icon

Sectoral Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Sectoral Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,383
Closed -$296K – 106
2025
Q1 		$296K Buy
44,383
+4,200
+10% +$41.5K 0.23% 62
2024
Q4 		$505K Sell
40,183
-3,200
-7% -$48.2K 0.34% 58
2024
Q3 		$801K Buy
43,383
+30,853
+246% +$632K 0.47% 54
2024
Q2 		$270K Sell
12,530
-2,280
-15% -$52.4K 0.11% 82
2024
Q1 		$399K Buy
14,810
+2,530
+21% +$71.9K 0.16% 79
2023
Q4 		$368K Sell
12,280
-214,750
-95% -$4.74M 0.16% 88
2023
Q3 		$4.65M Buy
227,030
+36,240
+19% +$659K 0.91% 47
2023
Q2 		$3.79M Hold
190,790
– – 0.63% 67
2023
Q1 		$3.27M Hold
190,790
– – 0.63% 67
2022
Q4 		$3.73M Sell
190,790
-80,000
-30% -$1.47M 0.72% 59
2022
Q3 		$4.32M Hold
270,790
– – 0.85% 53
2022
Q2 		$3.73M Sell
270,790
-33,185
-11% -$396K 0.75% 57
2022
Q1 		$4.82M Sell
303,975
-79,000
-21% -$1.36M 0.86% 48
2021
Q4 		$8.36M Sell
382,975
-123,110
-24% -$3.36M 1.26% 33
2021
Q3 		$15.1M Buy
506,085
+35,950
+8% +$1.31M 1.26% 23
2021
Q2 		$20.8M Buy
470,135
+22,250
+5% +$966K 1.68% 14
2021
Q1 		$19.9M Buy
447,885
+80,500
+22% +$4.42M 1.51% 23
2020
Q4 		$20.1M Buy
+367,385
New +$13.4M 1.42% 29
2018
Q3 		– Sell
-237,158
Closed -$4.66M – 172
2018
Q2 		$4.66M Buy
237,158
+21,000
+10% +$397K 0.52% 51
2018
Q1 		$4.05M Buy
+216,158
New +$3.52M 0.44% 58

Other funds holding RCKT

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Sectoral Asset Management's RCKT Position: Q2 2025 in Review

Sectoral Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 44,383 shares — an estimated $296K sold.

Sectoral Asset Management first reported a position in RCKT in Q1 2018 and held it in 20 quarters. The position peaked at $20.8M in Q2 2021. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Sectoral Asset Management reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 44,383 Rocket Pharmaceuticals shares in Q2 2025, an estimated $296K.
  • Sectoral Asset Management first reported a position in Rocket Pharmaceuticals in Q1 2018 and held it in 20 quarters.
  • Sectoral Asset Management's Rocket Pharmaceuticals position peaked at $20.8M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Sectoral Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.